Royalty Pharma Manager, LLC
SEC RegisteredFunding the next wave of biopharma innovation
About the firm
Royalty Pharma is the world's largest buyer of biopharmaceutical royalties and a leading funder of innovation in life sciences. The firm operates at the intersection of science, medicine and investing, with more than 60% global market share in the biopharma royalty funding space.
Firm Focus
Client segments reported on the firm's SEC Form ADV — applies to all advisors at the firm.
Areas of expertise
Services
Acquisition of biopharmaceutical royalties and provision of tailored funding solutions to partners in the biopharma ecosystem
Who they serve
Partners in the biopharma ecosystem, including those seeking tailored funding solutions and win-win partnerships in life sciences
| Client segment | Clients | Assets managed |
|---|---|---|
| Pension/Profit Sharing Plans | 2 | $18.5B |
Office locations
Regulatory & compliance
Data as of March 31, 2026 · Source: SEC IAPD & FINRA BrokerCheck
Contact Information
This profile was compiled and published by AdvisorFinder as editorial content using publicly available information from the SEC's IAPD database and FINRA BrokerCheck. Royalty Pharma Manager, LLC has not reviewed, approved, or endorsed this profile and is not responsible for its accuracy. Regulatory records change over time — always verify the current record directly on the SEC or FINRA websites before making any decision.
BrokerCheck data is used subject to the FINRA BrokerCheck Terms of Use. Found something inaccurate? Report inaccurate data and we will correct any error we introduced. Errors in the underlying BrokerCheck record itself are referred to FINRA, which maintains that record.
Find the right advisor for you
Take the free 3-minute assessment to get matched with advisors who fit your goals.
Get Matched